文献速递胰腺与胆道疾病消化内镜

胆道支架置入前内镜下乳头括约肌切开可预防胰腺炎:随机对照试验

Risk of Pancreatitis Following Biliary Stenting With/Without Endoscopic Sphincterotomy: A Randomized Controlled Trial.
PubMed 文献 · Clin Gastroenterol Hepatol · 2021-08-13

结果显示非ES组PEP发生率为20.6%,ES组为3.9%(P<.001),组间差异16.7%(95%CI 10.1%-23.3%),未落在6%的非劣效界值内。结论提示支架置入前行ES可预防PEP。

要点

  • 胆道狭窄患者支架置入前行ES可降低术后胰腺炎风险。
  • 非ES组PEP发生率20.6%,ES组3.9%,差异有统计学意义。
  • 除出血外,两组其他不良事件发生率无显著差异。

核心结论

  • 内镜下胆道支架置入前施行内镜下乳头括约肌切开对胆道狭窄患者具有预防术后胰腺炎的作用。

主要发现

  • 非ES组36例(20.6%)发生PEP,ES组7例(3.9%)发生PEP(P<.001)。
  • 符合方案人群中两组PEP发生率差异为16.7%(95%CI 10.1%-23.3%),未落在6%的非劣效界值内。
  • 除出血外,两组其他不良事件发生率无显著差异。

关键数值与推荐

  • 主要结局为首次经乳头胆道引流后2天内PEP发生率。
  • 次要结局为胆道支架/管置入相关的其他不良事件发生率。

临床怎么用

  • 对需内镜下胆道支架置入的胆道狭窄患者,可考虑在支架置入前先行内镜下乳头括约肌切开以降低PEP风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: The efficacy of endoscopic sphincterotomy (ES) before endoscopic transpapillary biliary drainage in preventing post-endoscopic retrograde cholangiopancreatography pancreatitis (PEP) has not been established. The aim of this study was to evaluate the effect of performing ES before biliary stent/tube placement on the occurrence of PEP. METHODS: Three hundred seventy patients with biliary stricture requiring endoscopic biliary stenting were enrolled and randomly allocated to the ES group (n = 185) or non-ES group (n = 185). All participants were followed up for 30 days after the procedure. The data and occurrence of adverse events were prospectively collected. The primary outcome measure of this study was the incidence of PEP within 2 days of initial transpapillary biliary drainage. Secondary outcome measures were the incidence of other adverse events related to biliary stent/tube placement. RESULTS: PEP occurred in 36 patients (20.6%) in the non-ES group and in 7 patients (3.9%) in the ES group (P < .001). The difference in the incidence of PEP between the 2 groups in the per-protocol population was 16.7% (95% confidence interval, 10.1%-23.3%), which was not within the noninferiority margin of 6%. Except for bleeding, the incidences of other adverse events were not significantly different between the groups. CONCLUSION: ES before endoscopic biliary stenting could have the preventive effect on the occurrence of PEP in patients with biliary stricture. University Hospital Medical Information Network Number, UMIN000025727.University Hospital Medical Information Network Clinical Trial Registry URL: https://www.umin.ac.jp/ctr/index.htm.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Kato S, Kuwatani M, Onodera M, et al. Risk of Pancreatitis Following Biliary Stenting With/Without Endoscopic Sphincterotomy: A Randomized Controlled Trial. Clin Gastroenterol Hepatol. 2021. PMID: 34391923. doi:10.1016/j.cgh.2021.08.016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。